Unique ID issued by UMIN | UMIN000002080 |
---|---|
Receipt number | R000002538 |
Scientific Title | A clinical research regarding an inhalation therapy of the low concentration carbon monoxide (CO) in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary artery hypertension (sPAH) |
Date of disclosure of the study information | 2009/06/16 |
Last modified on | 2009/06/16 16:32:30 |
A clinical research regarding an inhalation therapy of the low concentration carbon monoxide (CO) in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary artery hypertension (sPAH)
A clinical research regarding an inhalation therapy of the low concentration carbon monoxide (CO) in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary artery hypertension (sPAH)
A clinical research regarding an inhalation therapy of the low concentration carbon monoxide (CO) in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary artery hypertension (sPAH)
A clinical research regarding an inhalation therapy of the low concentration carbon monoxide (CO) in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary artery hypertension (sPAH)
Japan |
COPD and sPAH
Cardiology | Pneumology |
Others
NO
To study effects of low-concentration carboxy monoxide on the pulmonary artery hypertension, dyspnea on effort, blood coagulation, and inflammation in patients with COPD and sPAH
Safety,Efficacy
Exploratory
Explanatory
Not applicable
Mean pulmonary artery pressure
Dyspnea scale (Hugh-Jones scale), distance in 6 minutes walking test, lung function, lipid peroxide, and peripheral blood IL-10 level
Interventional
Single arm
Non-randomized
Open -no one is blinded
No treatment
1
Treatment
Device,equipment |
low dose carbon monoxide inhalation (50-100 ppm)
40 | years-old | <= |
Not applicable |
Male and Female
1.Stabe patients with chronic obstructive pulmonary disease and secondary pulmonary artery hypertension after recovery from acute exacerbation
2.Patients with stage II, III, and IV in GOLD criteria
3.Patients received chronic homeoxygen therapy
4.Patients agreed with written informed consent and to attend this trial with comprehension concerning significance of this research
1.Patients exposed to high level of ambient CO whose arterial Hb-CO (aHb-CO) concentration was more than 3.0%
2.Current smoker within 4 weeks
3.Patients with cardiac, hepatic, or hematologic diseases
4.Patients with abnormalities of blood coagulation or fibrinolysis
20
1st name | |
Middle name | |
Last name | Hiroyasu Yasuda |
Tohoku University
Department of Translational Research Center
1-1 Seiryo-machi, Aoba-ku, Sendai, Japan
1st name | |
Middle name | |
Last name |
Tohoku University
Department of Translational Research Center
Tohoku University
Grant-In-Aid for Scientific Research
NO
2009 | Year | 06 | Month | 16 | Day |
Unpublished
Completed
2006 | Year | 06 | Month | 19 | Day |
2006 | Year | 06 | Month | 01 | Day |
2007 | Year | 04 | Month | 01 | Day |
2007 | Year | 04 | Month | 01 | Day |
2007 | Year | 04 | Month | 01 | Day |
2007 | Year | 04 | Month | 01 | Day |
2009 | Year | 06 | Month | 16 | Day |
2009 | Year | 06 | Month | 16 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002538
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |